Notably, the overall ac4C levels of the cancer cells were significantly decreased in NAT10‐deficient cancer cells post transfected with NAT10 siRNA, suggesting that the NAT10‐deficient cancer cells have reduced ac4C levels as well as global acetylated RNAs due to NAT10‐mediated ac4C reduction (Figure 1E). Here, NAT10 is linked to cancer.